April's list of pharmaceutical events: The performance of Chinese pharmaceutical companies deserves attention

　　At the end of the first quarter of 2020, the pharmaceutical industry's relevant list and ranking son and order were released, including the "Pharmaceutical Industry Innovation Index", "Pharmaceutical Invention Index" list, "2019 Top 100 Medical Device Companies List" and so on In addition, there are hospital drug sales, drug company Q1 market value, 2019 multinational pharmaceutical company CEO annual salary ranking The author of this brief combing, only for the medical industry industry industry reference
The "Pharmaceutical Industry Innovation Index" and "Pharmaceutical Invention Index" list released idea Pharma has released the 10th annual "Pharmaceutical Industry Innovation Index" list, Roche first ranked high in the index At the same time, also released the pharmaceutical industry's 2nd "Pharmaceutical Industry Invention Index" ranking, AstraZeneca in the pipeline to maintain the industry leader position
It is worth noting that in this list, there is a Chinese pharmaceutical company - Hengrui Pharmaceuticals on the list, and for the first time on the list It ranks 13th in the Pharmaceutical Industry Innovation Index, behind GSK, and 15th in the Pharmaceutical Invention Index, alongside two other pharmaceutical companies
2019 hospital drug sales TOP50 released in April, 2019 national sample hospital drug sales TOP50 fresh out, TOP50 total sales of 76.414 billion yuan, the threshold of 910 million yuan Among them, the top three drugs on the list are human albumin, sodium chloride, yew alcohol, sales of 3.79 billion yuan, 3.469 billion yuan, 3,053 million yuan
It is worth noting that in many drugs, domestic innovative drugs only three raw pharmaceutical sansheng pharmaceutical 1 class of biological products recombinant human platelet-based products on the list, the rest are imported original research drugs or domestic generic drugs occupy the list
On April 23rd GlobalData, a data analytics and consulting firm, released market cap situ rankings and changes for the top 20 innovative pharmaceutical companies in the world in the first quarter of 2020 According to the report, 13 of the top 20 companies by market capitalisation fell in value, with Johnson and Johnson down 10 per cent, Novartis down 10.1 per cent, Mercado down 15.7 per cent and Pfizer down 16.7 per cent Among them, Bayer was the biggest faller, with a 28.5 percent plunge But it's worth noting that the two pharmaceutical companies, Regenerative Yuan and Gilead Science, have not bucked the price, with market capitalisation rising by more than 10%
The top three CRO-listed companies (A-shares) in 2019 ranked the 2019 CRO-listed companies (A-shares) revenue It is worth noting that the top three of these companies accounted for nearly $20 billion in total revenue, accounting for the majority of all the total revenue of all companies on the list The three companies are Pharmaceutical MingKangde (12.9 billion yuan), Kanglong Huacheng (3,757 million yuan) and Tiger Pharma (2.803 billion yuan)
The top five annual salaries of CEOs of multinational pharmaceutical companies in 2019 Are gradually announced after the annual reports of companies are published, and the salaries of A number of multinational pharmaceutical companies, such as Johnson and Johnson, AstraZeneca, Pfizer, Roche, Novartis, GSK and other pharmaceutical companies, have also been announced Among them, the TOP five CEO compensation is from Johnson and Johnson, Lilly, Amgen, AstraZeneca, Pfizer, the five large pharmaceutical companies Johnson and Johnson CEO Alex Gorky received a total salary of $25.37 million, up 26.9 percent from 2018, notably due to an increase in pensions
Recently, QMED released the 2019 Top 100 Medical Device Companies List, which ranks the world's medical device companies based on their revenue in 2019
The top 10 medical device companies had total revenue of $194.428 billion, with 51 medical device companies worldwide earning more than $1 billion It is worth noting that five medical device companies in China are on the list: Murray Medical (42), Xinhua Medical (58), Lepu Medical (61), Micro-Invention Medical (80), and Fish Leap Medical (85)
FiercePharma, the drug that is expected to grow in sales to TOP10 in 2020, compiles a list of the top 10 drugs expected to grow in sales in 2020 based on evaluatePharma's 2020 analysis In terms of the list, Mercado's Keytruda topped the list, with EvaluatePharma predicting keytruda's 2020 sales would exceed $3.2 billion, as did Gilead's Biktarvy and PepsiCo's Eevlimid.